Laurus Labs Limited (BOM:540222)
India · Delayed Price · Currency is INR 1,114.50
-15.15 (-1.34%)
At close: Apr 21, 2026
Laurus Labs Employees
Laurus Labs had 6,167 employees as of March 31, 2025. The number of employees increased by 160 or 2.66% compared to the previous year.
Employees
6,167
Change (1Y)
160
Growth (1Y)
2.66%
Revenue / Employee
10.90M INR
Profits / Employee
1.37M INR
Market Cap
601.59B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 6,167 | 160 | 2.66% |
| Mar 31, 2024 | 6,007 | 254 | 4.42% |
| Mar 31, 2023 | 5,753 | 449 | 8.47% |
| Mar 31, 2022 | 5,304 | 496 | 10.32% |
| Mar 31, 2021 | 4,808 | 936 | 24.17% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IOL Chemicals and Pharmaceuticals | 2,891 |
| Neuland Laboratories | 1,794 |
| Shilpa Medicare | 998 |
| Bajaj HealthCare | 918 |
| NGL Fine-Chem | 520 |
| Sai Parenteral's | 296 |
| Gujarat Themis Biosyn | 221 |
| Influx Healthtech | 163 |
Laurus Labs News
- 14 days ago - Laurus Labs receives creditor approval for composite scheme of arrangement - Business Upturn
- 4 weeks ago - Pharma sector stocks today, March 24: Shilpa Medicare jumps 3.28%, Glenmark Pharma up 1.36%, Laurus Labs gain 1.65% - Business Upturn
- 4 weeks ago - Pharma sector stocks surge today, March 20: Laurus Labs jumps 2.83%, Natco Pharma up 2.67%, Aurobindo Pharma gains 2.42% - Business Upturn
- 4 weeks ago - Pharma sector stocks fall today, March 19: Biocon down 2.33%, Laurus Labs falls 2.29%, Glenmark Pharma drops 2% - Business Upturn
- 5 weeks ago - Pharma sector stocks today, March 13: Laurus Labs down 2.56%, Ajanta Pharma falls 1.88%, Granules India drops 2.14% - Business Upturn
- 6 weeks ago - Pharma sector fall sharply otday, March 9: Laurus Labs down 3%, Glenmark Pharma drops 2.44%, Zydus Life falls 2.10% - Business Upturn
- 3 months ago - Laurus Labs Ltd (BOM:540222) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 3 months ago - Q3 2026 Laurus Labs Ltd Earnings Call Transcript - GuruFocus